do transdermal glp 1 patches work Work? The Honest Clinical Answer GLP-1 Patches: What are They,

References Buse JB, Drucker DJ, Taylor KL, Kim T, Walsh B, Hu H, et al

[25] Cancer [edit] In response to a report of precancerous changes in the pancreases of rats and organ donors treated with the DPP-4 inhibitor sitagliptin, [26] [27] the US FDA and the European Medicines Agency each undertook independent reviews of all clinical and preclinical data related to the possible association of DPP-4 inhibitors with pancreatic cancer

The company noted the candidate's competitive safety profile and sustained efficacy over 28 weeks, with plans to advance it into Phase 3 trials in 2026

In addition, a large-scale clinical study demonstrated that GLP-1 analogues could reduce the mortality of patients with prostate cancer and diabetes (210, 224)

R: a language and environment for statistical computing